Catherine L. Kelleher

525 total citations
12 papers, 364 citations indexed

About

Catherine L. Kelleher is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Catherine L. Kelleher has authored 12 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Catherine L. Kelleher's work include Genetic and Kidney Cyst Diseases (4 papers), Vasculitis and related conditions (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Catherine L. Kelleher is often cited by papers focused on Genetic and Kidney Cyst Diseases (4 papers), Vasculitis and related conditions (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Catherine L. Kelleher collaborates with scholars based in United States, United Kingdom and France. Catherine L. Kelleher's co-authors include Robert W. Schrier, Margaret Johnson, Kimberly K. McFann, Amirali Masoumi, Søren K. Moestrup, Takeshi Matsuyama, Robert J. Unwin, Hiroshi Shiraga, Takashi Igarashi and Kim McFann and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Annals of the Rheumatic Diseases.

In The Last Decade

Catherine L. Kelleher

12 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine L. Kelleher United States 8 186 183 83 72 58 12 364
Vickie Hannig United States 12 175 0.9× 185 1.0× 21 0.3× 18 0.3× 83 1.4× 19 494
Jessica Liao United States 4 255 1.4× 118 0.6× 17 0.2× 105 1.5× 27 0.5× 5 354
Haruna Kawano Japan 9 158 0.8× 182 1.0× 44 0.5× 72 1.0× 22 0.4× 22 283
Mohammad Al-Haggar Egypt 11 87 0.5× 53 0.3× 13 0.2× 37 0.5× 81 1.4× 47 330
Eungu Kang South Korea 13 171 0.9× 127 0.7× 10 0.1× 25 0.3× 22 0.4× 47 436
Débora Braslavsky Argentina 12 239 1.3× 187 1.0× 32 0.4× 20 0.3× 50 0.9× 25 454
Shiguo Liu China 12 155 0.8× 26 0.1× 91 1.1× 37 0.5× 63 1.1× 45 455
Régine Perrichot France 8 359 1.9× 412 2.3× 115 1.4× 82 1.1× 72 1.2× 14 508
Olga Beltcheva Bulgaria 8 166 0.9× 82 0.4× 177 2.1× 37 0.5× 14 0.2× 18 314
Sadaki Sakane Japan 9 85 0.5× 45 0.2× 12 0.1× 41 0.6× 24 0.4× 37 387

Countries citing papers authored by Catherine L. Kelleher

Since Specialization
Citations

This map shows the geographic impact of Catherine L. Kelleher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine L. Kelleher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine L. Kelleher more than expected).

Fields of papers citing papers by Catherine L. Kelleher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine L. Kelleher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine L. Kelleher. The network helps show where Catherine L. Kelleher may publish in the future.

Co-authorship network of co-authors of Catherine L. Kelleher

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine L. Kelleher. A scholar is included among the top collaborators of Catherine L. Kelleher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine L. Kelleher. Catherine L. Kelleher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Merkel, Peter A., David Jayne, H. Yue, et al.. (2020). OP0011 A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED STUDY OF AVACOPAN IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS. Annals of the Rheumatic Diseases. 79. 8–8. 7 indexed citations
2.
Kelleher, Catherine L. & Hetal S. Kocinsky. (2020). Novel Complement Therapeutics in Development as Potential Treatment for Renal Disease. Advances in Chronic Kidney Disease. 27(2). 95–103. 3 indexed citations
3.
Jayne, David, Peter A. Merkel, Huibin Yue, et al.. (2020). Complement C5a Receptor Inhibitor Avacopan Improves Renal Function in ANCA Vasculitis. Journal of the American Society of Nephrology. 31(10S). 53–53. 1 indexed citations
4.
Jayne, David, Peter A. Merkel, Huibin Yue, et al.. (2020). LB003A RANDOMIZED, DOUBLE-BLIND, ACTIVE CONTROLLED STUDY OF AVACOPAN IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS. Nephrology Dialysis Transplantation. 35(Supplement_3). 3 indexed citations
5.
Robinson, Penelope J., et al.. (2016). FRI0613-HPR Do Physiotherapists Document Weight and Discuss The Influence of Weight on Pathology in Patients with Osteoarthritis?. Annals of the Rheumatic Diseases. 75. 1275–1275. 1 indexed citations
6.
Chung, Seon-Yoon, Shijun Zhu, Erika Friedmann, et al.. (2015). Weight loss with mindful eating in African American women following treatment for breast cancer: a longitudinal study. Supportive Care in Cancer. 24(4). 1875–1881. 38 indexed citations
7.
Reed, Berenice, Kim McFann, William J. Kimberling, et al.. (2008). Presence of De Novo Mutations in Autosomal Dominant Polycystic Kidney Disease Patients Without Family History. American Journal of Kidney Diseases. 52(6). 1042–1050. 48 indexed citations
8.
Reed, Berenice, Kim McFann, Mir Reza Bekheirnia, et al.. (2008). Variation in Age at ESRD in Autosomal Dominant Polycystic Kidney Disease. American Journal of Kidney Diseases. 51(2). 173–183. 34 indexed citations
9.
Masoumi, Amirali, Berenice Reed-Gitomer, Catherine L. Kelleher, & Robert W. Schrier. (2007). Potential Pharmacological Interventions in Polycystic Kidney Disease. Drugs. 67(17). 2495–2510. 22 indexed citations
10.
Kelleher, Catherine L., Kimberly K. McFann, Margaret Johnson, & Robert W. Schrier. (2004). Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population. American Journal of Hypertension. 17(11). 1029–1034. 81 indexed citations
11.
Norden, Anthony G.W., Marta Lapsley, Takashi Igarashi, et al.. (2002). Urinary Megalin Deficiency Implicates Abnormal Tubular Endocytic Function in Fanconi Syndrome. Journal of the American Society of Nephrology. 13(1). 125–133. 99 indexed citations
12.
Kelleher, Catherine L., et al.. (1998). CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphatemic rickets. Kidney International. 53(1). 31–37. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026